BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18645150)

  • 1. Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients.
    Buettiker UV; Yawalkar NY; Braathen LR; Hunger RE
    Arch Dermatol; 2008 Jul; 144(7):943-5. PubMed ID: 18645150
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna.
    Micantonio T; Fargnoli MC; Peris K
    Arch Dermatol; 2006 Apr; 142(4):530-1. PubMed ID: 16618884
    [No Abstract]   [Full Text] [Related]  

  • 3. Image in clinical medicine. Lentigo maligna.
    Noel B; Kunzle N
    N Engl J Med; 2005 Nov; 353(20):2176. PubMed ID: 16291987
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
    van Meurs T; van Doorn R; Kirtschig G
    Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589
    [No Abstract]   [Full Text] [Related]  

  • 5. [Imiquimod in the treatment of lentigo maligna].
    Nagore E; Botella-Estrada R
    Actas Dermosifiliogr; 2011 Oct; 102(8):559-62. PubMed ID: 21536245
    [No Abstract]   [Full Text] [Related]  

  • 6. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
    Powell AM; Russell-Jones R
    J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentigo maligna successfully treated with imiquimod.
    du Plessis PJ
    S Afr J Surg; 2007 May; 45(2):72. PubMed ID: 17674567
    [No Abstract]   [Full Text] [Related]  

  • 8. Imiquimod in the treatment of extensive recurrent lentigo maligna.
    Kamin A; Eigentler TK; Radny P; Bauer J; Weide B; Garbe C
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):51-2. PubMed ID: 15692515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentigo maligna managed with topical imiquimod and dermoscopy: report of two cases.
    de Troya-Martín M; Frieyro-Elicegui M; Fúnez Liébana R; Aguilar Bernier M; Fernández-Canedo NI; Blázquez Sánchez N
    Dermatol Surg; 2008 Nov; 34(11):1561-6. PubMed ID: 18798748
    [No Abstract]   [Full Text] [Related]  

  • 10. [Topical imiquimod as palliative therapy for extensive lentigo maligna on the cheek].
    Cheikhrouhou H; Pouaha J; Claeys A; Truchetet F
    Ann Dermatol Venereol; 2010 Feb; 137(2):142-4. PubMed ID: 20171439
    [No Abstract]   [Full Text] [Related]  

  • 11. Amelanotic lentigo maligna managed with topical imiquimod.
    Lapresta A; García-Almagro D; Sejas AG
    J Dermatol; 2012 May; 39(5):503-5. PubMed ID: 21973079
    [No Abstract]   [Full Text] [Related]  

  • 12. Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream.
    Chapman MS; Spencer SK; Brennick JB
    Arch Dermatol; 2003 Jul; 139(7):943-4. PubMed ID: 12873902
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical imiquimod treatment of lentigo maligna: clinical and histologic evaluation.
    Kupfer-Bessaguet I; Guillet G; Misery L; Carre JL; Leroy JP; Sassolas B
    J Am Acad Dermatol; 2004 Oct; 51(4):635-9. PubMed ID: 15389205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive lentigo maligna clearing with topical imiquimod.
    Epstein E
    Arch Dermatol; 2003 Jul; 139(7):944-5. PubMed ID: 12873903
    [No Abstract]   [Full Text] [Related]  

  • 15. [Imiquimod treatment of lentigo maligna to dermoscopic and histologic clearance].
    Lorentzen HF; Weismann K
    Ugeskr Laeger; 2005 Sep; 167(39):3696-7. PubMed ID: 16219219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of a hemifacial lentigo maligna treated using 5% imiquimod.
    Ramsdell AM; Zeitouni N
    Dermatol Surg; 2009 Feb; 35(2):287-90. PubMed ID: 19215272
    [No Abstract]   [Full Text] [Related]  

  • 17. Lentigo maligna treated with topical imiquimod: dermatoscopy usefulness in clinical monitoring.
    Costa MC; Abraham LS; Barcaui C
    An Bras Dermatol; 2011; 86(4):792-4. PubMed ID: 21987152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of lentigo maligna with imiquimod 5% cream.
    Hopson B; Richey D; Sajben FP
    J Drugs Dermatol; 2007 Oct; 6(10):1037-40. PubMed ID: 17966182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod.
    Woodmansee CS; McCall MW
    Dermatol Surg; 2009 Aug; 35(8):1286-9. PubMed ID: 19438661
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.
    Fisher GH; Lang PG
    Arch Dermatol; 2003 Jul; 139(7):945-7. PubMed ID: 12873904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.